Glaucoma risk factors


Greater understanding of the nature and role of risk factors for the onset and progress of glaucoma is a complex task that requires the collaboration of epidemiology, basic sciences and clinical trials, according to a study presented at the 2011 World Glaucoma Congress. “The risk estimates for glaucoma depend on disease definition and are sample specific,†said Paul Healey MD, PhD, clinical associate professor at the University of Sydney, Australia. “One of the problems many ophthalmologists have is that there are so many different studies out there showing so many different risk factors and it is rather hard to decipher what is important and what is not, as the impact of a risk factor may vary across different populations and disease states,†he added.
Defining a risk factor as a factor associated with an increased occurrence of a disease, Dr Healey said it is vital to ensure that the identified risk factor is not completely explained by a co-related factor (confounding) or an inappropriate comparison (bias).
“Those two aspects separate many purported risk factors in many studies from what are probably true risk factors. Hence, the most important thing to do when reviewing a paper purporting to show a risk factor for glaucoma is to question whether there could be a correlated factor or an inappropriate comparison that explains it,†he said.
[/caption]
The next step is to establish whether the identified risk factor is a causal risk factor that leads directly to the disease. If the risk factor is causal, then removing that risk factor should reduce or remove the disease itself, said Dr Healey.
“Risk factors are not always causal, however. They may be surrogates for true causal risk factors that we have not been able to discover or do not have the technology to discover, or they could be epi-phenomena on the causal pathway. These are reliable features that are strongly associated with the glaucoma, but the removal of which does not reduce the risk of disease progression†he said.
Proving a causal risk factor is a complex task, with the first step being to rule out biases or possible confounders, said Dr Healey. This needs robust study design and standardised statistical methodology.
“It really requires a number of high-quality studies that are well conducted and independent from each other that show similar risk factors and a similar magnitude of risk. A good example is IOP, which has been very well described and its association with glaucoma by many independent studies,†he said.
The next step is to identify a plausible biological link between the risk factor and the disease, said Dr Healey.
“This is the role of much of the basic laboratory science, to describe how what we find in a clinical or epidemiological study is linked to the disease, and it usually entails understanding the cellular mechanisms involved. We also need to show a reduction in disease progression in people not exposed to the risk factor and that of course requires randomised controlled interventional trials or sometimes cohort studies,†he said.
Other factors which need to be borne in mind when identifying risk factors are the varying definitions of glaucoma across different studies, taking account of whether the study was looking at early onset or more advanced disease, and whether patient groups had diagnosed or undiagnosed glaucoma, said Dr Healey.
While multivariate modelling can help in adjusting the correlation to risk factors, some interactions may still persist, said Dr Healey.
“A perfect example of that are vascular risk factors. There are so many different measurements that can be made relating to vascular risk, heart attack, stroke status, systolic blood pressure, perfusion pressure, mean blood pressure and so forth, that it is very hard to tease out which one or group of these is actually more important,†he said.
Latest Articles
Towards a Unified IOL Classification
The new IOL functional classification needs a strong and unified effort from surgeons, societies, and industry.
The 5 Ws of Post-Presbyopic IOL Enhancement
Fine-tuning refractive outcomes to meet patient expectations.
AI Shows Promise for Meibography Grading
Study demonstrates accuracy in detecting abnormalities and subtle changes in meibomian glands.
Are There Differences Between Male and Female Eyes?
TOGA Session panel underlined the need for more studies on gender differences.
Simulating Laser Vision Correction Outcomes
Individualised planning models could reduce ectasia risk and improve outcomes.
Need to Know: Aberrations, Aberrometry, and Aberropia
Understanding the nomenclature and techniques.
When Is It Time to Remove a Phakic IOL?
Close monitoring of endothelial cell loss in phakic IOL patients and timely explantation may avoid surgical complications.
Delivering Uncompromising Cataract Care
Expert panel considers tips and tricks for cataracts and compromised corneas.
Organising for Success
Professional and personal goals drive practice ownership and operational choices.